Table 3.
Analytical performance of selected electrochemical aptasensors for VEGF165.
Strategy | Technique | LOD, M | Interference Studies |
Ref. |
---|---|---|---|---|
Sandwich Apt/MBs-Ab/VEGF/Apt/AuIDE | EIS (capacitance) | 10.5 × 10−12
(401 pg mL−1) |
BSA | [179] |
NP/Strp-ALP/B-Apt/VEGF/MCH/SH-Apt/AuNPs/SPGE | DPV | 3 × 10−8 | HER2 | [180] |
MB/Apt/GA/BSA-AuNCs/IL/GCE Apt/GA/BSA-AuNCs/IL/GCE |
DPV EIS (Ferri/ferrocyanide) |
signal-off: 0.32 × 10−12 signal-on: 0.48 × 10−12 |
Not shown | [169] |
SH-Apt/OMC–Aunano/SPCE | EIS (Ferri/ferrocyanide) | 26.2 × 10−15
(1 pg mL−1) |
HIgG, HIgA, Lip, Lyz, HSA | [181] |
Fc-Apt-alkyne/UDT + UDT-N3/Au | ACV | 6.2 × 10−9 | VEGF121, BSA, HSA, trypsin | [182] |
DNA-Ag/Pt NCs/amino-Apt/GCE Peroxidase mimicking activity |
Amp | 4.6 × 10−12 | Thr, HSA, HIgG | [183] |
MCH/SH-Apt-MB/Au | SWV | 3.93 × 10−12
(0.15 ng mL−1) |
AA, UA | [184] |
Apt/Aunano/rGO-PAMAM-Th/SPCE | DPV | 0.7 × 10−12 | U, AA, D, Glu, HIgG, HIgA | [185] |
BPEI-Fc-CB[7]-N3-GO/S1/MCH/S2/SH-Apt/Au | SWV | 0.21 × 10−15
(8 fg mL−1) |
BSA, HSA, VEGFR1, VEGFR2, VEGF121 | [171] |
MB/NH2-Apt/GA/AP/IL/GCE NH2-Apt/GA/AP/IL/GCE |
DPV EIS (Ferri/ferrocyanide) |
signal-off: 0.5 × 10−12 signal-on: 0.78 × 10−12 |
Not shown | [172] |
Hairpin DNA/AuNPs/GQD/Thi/MCH/SH-hairpin DNA/Au | SWV | 0.3 × 10−15 | PSA, BSA, Thr | [173] |
Peptide Apt-based functionalised microneedles | EIS (capacitance) | 0.1 × 10−12 | HIgG, Con A, cholera toxin | [23] |
SH-Apt/AuNAs@NC/Au | EIS (Ferri/ferrocyanide) | 0.18 × 10−12
(6.77 pg mL−1) |
Lyz, HIgG, CEA, PSA | [174] |
SH-Apt/LPLE | EIS | 0.017 × 10−15
(0.64 fg mL−1) |
Thr, PDGF-BB; VEGF121, HIgG | [178] |
Sandwich Apt-GDH/VEGF/Biotin-Ab/ strp/DTBSU/AuWE |
Amp | 105 × 10−12 | BSA | [177] |
biotin-Apt-Fc/MB-strp/GO-GCE biotin-Apt-Fc/MB-strp/GO-PhA-GCE |
SWV | 2.62 × 10−15
(1 pg mL−1) 0.18 × 10−12 (7 pg mL−1) |
IL-6, CA-125, PSA, HIgG | [175] |
SH-Apt-Fc + SH-PEG/AuNPs-MB/rGO-GCE | SWV | 2.62 × 10−15
(0.1 pg mL−1) |
HIgG, IL-1β, PSA, IL-6 | [176] |
Abbreviations: AuIDE—interdigitated electrodes; Apt-aptamer; MBs—magnetic beads; Ab—antibody; VEGF—vascular endothelial growth factor; SWV—Square Wave Voltammetry; EIS—electrochemical impedance spectroscopy; DPV—Differential Pulse; Amp—amperometry; NP—1-naphthyl-phosphate; Strp-ALP—streptavidin-alkaline phosphatase conjugate; B-Apt—Biotinylated Apt; AuNPs/SPGE—Gold nanostructured graphite screen printed electrodes; GA—glutaraldehyde; BSA-AuNCs—BSA-gold nanoclusters; IL—ionic liquid; GCE—glassy carbon electrode; Au/GQD—Gold/graphene quantum dot hybrid; OMC–Aunano mesoporous carbon–gold nanocomposite; HER2—human epidermal growth factor receptor 2; HIgG—human immunoglobulin G; HIgA—human immunoglobulin A; Lip—lipase; Lyz—lysozyme; HSA—human serum albumin; UDT-N3—11-Azido-1-undencanethiol; ACV—alternating current voltammetry; DNA-Ag/Pt NCs—DNA bimetallic Ag/Pt nanoclusters; Thr—human thrombin; SPCE—screen-printed carbon electrode; rGO-PAMAM/Aunano–reduced graphene oxide/gold functionalised with poly(amidoamine) dendrimers; U—urea; AA—ascorbic acid; D—dopamine; Glu—glucose; BPEI–branched ethylene imine polymer; Fc—aminomethylferrocene; CB[7]-cucurbit[7]urils macrocycle; N3-GO–azide-functionalised graphene oxide; S1—alkyne-functionalised DNA strand; MCH—6-mercaptohexan-1-ol; S2–hairpin DNA strand; AP–Au-Pd alloy; IL–ionic liquid; Con A—concanavalin A; AuNAs@NC–Au nanoarchitecture embedded with nanochitosan; CEA—carcinoembryonic antigen; LPLE—label-free line-pad-line; PDGF-BB—platelet-derived growth factor-BB; GDH—glucose dehydrogenase; Amp—amperometry; Biotin-Ab—biotinylated antibody; DTBSU—dithiobis(succinimidy undecanoate); AuWE—gold wire electrode; GO/MB—methylene blue loaded graphene oxide; PhA—physical adsorption; SH-PEG—thiol-modified polyethylene glycol; IL-6—interleukin-6; PSA—prostate specific antigen; IL-1β—interleukin-1β.